Normal range | PSIS | Hypoplasia | Normal | Tumor-survivor | P1 | P2 | P3 | P4 | P5 | P6 | |
---|---|---|---|---|---|---|---|---|---|---|---|
FT4 | 12–22 pmol/L | 9.82 ± 2.75 | 12.31 ± 3.07 | 12.75 ± 2.07 | 11.23 ± 3.58 | ≤0.001 | 0.002 | 0.008 | 0.682 | 0.200 | 0.198 |
TSH | 0.27–4.2 μIU/ml | 1.03 ± 1.08 | 1.38 ± 1.47 | 2.49 ± 1.53 | 0.76 ± 1.15 | 0.193 | ≤0.001 | 0.149 | 0.056 | 0.045 | ≤0.001 |
IGF-1 | 111–555 ng/ml | 33.60 ± 16.44 | 45.49 ± 44.67 | 41.69 ± 22.29 | 48.57 ± 34.19 | 0.039 | 0.159 | ≤0.001 | 0.800 | 0.737 | 0.543 |
GH peak | > 10.00 ng/ml | 1.37 ± 1.78 | 1.27 ± 1.52 | 3.36 ± 1.79 | 0.53 ± 0.52 | 0.801 | ≤0.001 | ≤0.001 | 0.002 | 0.002 | ≤0.001 |
COR | 172–497 nmol/l | 110.88 ± 103.05 | 222.73 ± 124.03 | 215.00 ± 217.30 | 134.48 ± 171.48 | ≤0.001 | 0.009 | 0.294 | 0.896 | 0.025 | 0.193 |
ACTH | 7.2–63.3 pg/ml | 27.50 ± 20.72 | 25.05 ± 14.64 | 34.61 ± 59.35 | 7.19 ± 8.63 | 0.587 | 0.423 | ≤0.001 | 0.458 | ≤0.001 | ≤0.001 |
FSH peaka | mIU/ml | 1.28 ± 1.36 b | 1.28 ± 1.05c | /d | 0.22 ± 0.21e | > 0.99 | / | 0.019 | / | 0.006 | / |
LH peaka | mIU/ml | 0.36 ± 0.58 | 1.03 ± 1.45 | / | 0.14 ± 0.08 | 0.038 | / | 0.242 | / | 0.069 | / |
Ta | ng/ml | 0.26 ± 0.65 | 0.44 ± 0.93 | / | 0.45 ± 0.69 | 0.507 | / | 0.429 | / | 0.979 | / |